Icosavax Inc (ICVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -5,851 | -18,854 | -14,246 | -8,669 |
| Depreciation Amortization | 1 | 1 | N/A | N/A |
| Accounts payable and accrued liabilities | -205 | N/A | 590 | 130 |
| Other Working Capital | 169 | 4,158 | 1,748 | 469 |
| Other Operating Activity | 1,704 | 487 | 1,388 | -13 |
| Operating Cash Flow | $-4,182 | $-14,208 | $-10,520 | $-8,083 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -134 | -11 | -10 | -5 |
| Investing Cash Flow | $-134 | $-11 | $-10 | $-5 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 120 | N/A | 172 | 66 |
| Other Financing Activity | 113,659 | 6,638 | 4,756 | 0 |
| Financing Cash Flow | $113,779 | $6,638 | $4,928 | $66 |
| Beginning Cash Position | 15,498 | 23,079 | 23,079 | 23,079 |
| End Cash Position | 124,961 | 15,498 | 17,477 | 15,057 |
| Net Cash Flow | $109,463 | $-7,581 | $-5,602 | $-8,022 |
| Free Cash Flow | ||||
| Operating Cash Flow | -4,182 | -14,208 | -10,520 | -8,083 |
| Capital Expenditure | -134 | N/A | -10 | -5 |
| Free Cash Flow | -4,316 | -14,208 | -10,530 | -8,088 |